
針對美國國際貿易委員會(USITC)啟動337條款專利侵權調查,鴻海表示經初步評估目前未對生產營運造成重大影響,已組專業團隊積極應對。
AI-generated summary
美國電源技術廠Vicor於9月9日提出申訴,指控部分進口及銷售的垂直供電系統涉嫌侵犯專利。
鴻海強調,目前案件尚處於立案初期,USITC僅決定啟動調查,尚未就美國Vicor Corporation提出的侵權主張作出任何實質認定。
針對美國國際貿易委員會(USITC)正式啟動337條款專利侵權調查,鴻海(2317)今日指出,經初步評估,本次調查目前未對公司及相關企業的生產營運、產品出貨及客戶合作造成重大影響,整體營運維持正常,並已組成專業團隊釐清相關專利及產品範圍,將依照法定程序積極應對。
鴻海表示,本次調查涉及美國專利「US 10903734」,調查範圍包括特定垂直供電系統、相關組件,以及搭載該等系統的運算系統,鴻海及旗下工業富聯(Foxconn Industrial Internet)、FII USA、Ingrasys Technology及Ingrasys Technology USA等相關企業均被列為被調查方。
鴻海強調,目前案件尚處於立案初期,USITC僅決定啟動調查,尚未就美國Vicor Corporation提出的侵權主張作出任何實質認定。公司尊重智慧財產權,將持續與客戶及供應鏈合作夥伴保持溝通,維護公司及股東權益。
根據USITC公告,美國電源技術廠Vicor於9月9日提出申訴,並於隔日補充資料,指控部分進口美國及在美國銷售的垂直供電系統、相關零組件及運算系統涉嫌侵犯專利,要求USITC發布有限排除令及停止及禁止令,限制涉及侵權的相關產品進口及銷售。
此次調查除鴻海集團外,台灣科技廠台達電(2308)、廣達(2382)及旗下相關企業也被列入名單,其他受調查企業包括英飛凌、立訊精密、芯源系統(MPS)、偉創力及天弘等。
USITC指出,啟動調查不代表已認定相關企業侵權,後續將由行政法官進行審理,並於立案後45天內設定調查完成的目標日期。鴻海表示,本案後續結果仍存在不確定性,將密切關注調查進展及可能影響,並依相關法令辦理資訊揭露。
AI outlook — possibilities, not facts
行政法官將設定調查完成的目標日期
Very likely · Within weeks

In September, Ningbo Zhoushan Port completed container throughput of 4.27 million TEUs, a year-on-year increase of 11.5%, reaching a record high. At present, the average waiting time for berthing has returned to about one day, and the production situation in Hong Kong is stable and orderly.

Data released by the financial data platform "Moneymind Hub" shows that as of October 7 this year, the best-performing stock market in the world is Taiwan, with an increase of 69.8%, ranking first in the world, South Korea and Japan ranked second and third, and China and Hong Kong showed negative returns.
Adidas Group Global CEO Bjorn Goulden said in Shanghai that the company is "very optimistic" about China and Shanghai's sports and sports fashion market. It has achieved high-quality growth for 13 consecutive quarters and will continue to invest in Chinese sports, retail networks and local innovation in the future.

TSMC is expected to hold a press conference on October 15. The US media "The Motley Fool" pointed out that it will become an important indicator for observing Huida's operating prospects. The market focuses on the three major indicators of high-performance computing revenue, CoWoS production capacity and full-year financial forecast.

On October 11, Harbin Pharmaceutical Co., Ltd. issued an announcement stating that the company’s director and president Lu Chuanyou received the “Notice of Filing” and “Notice of Lien” from the relevant supervisory committee. The company stated that the current production and operation conditions are normal.

Due to the emptiness of public finances and local financial difficulties, the Chinese authorities have recently targeted wealthy individuals with overseas investments, using data from the joint declaration system to recover property taxes on overseas investments, requiring tax arrears for the past three to five years to be paid before the end of October, triggering panic and uneasiness among the wealthy.